trending Market Intelligence /marketintelligence/en/news-insights/trending/HrswPXHZMgG_QYEwy9spJg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

AbbVie ordered to pay $15M in birth defect trial

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


AbbVie ordered to pay $15M in birth defect trial

A federal jury asked AbbVie Inc. to pay $15 million in compensatory damages to Stevie Gonzalez, who was born with spina bifida, Reuters reported.

Spina bifida is a birth defect where there is an incomplete closing of the backbone and membranes around the spinal cord.

Gonzalez's mother blamed the 10-year-old boy's birth defect on Depakote in one of many lawsuits against AbbVie's bipolar disorder drug.

Christina Raquel said she was not adequately warned about a risk of birth defects when she took Depakote while pregnant.